These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9816326

  • 1. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.
    Chan HS, DeBoer G, Thiessen JJ, Budning A, Kingston JE, O'Brien JM, Koren G, Giesbrecht E, Haddad G, Verjee Z, Hungerford JL, Ling V, Gallie BL.
    Clin Cancer Res; 1996 Sep; 2(9):1499-508. PubMed ID: 9816326
    [Abstract] [Full Text] [Related]

  • 2. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 5. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP, Shields C, Meadows AT.
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
    Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, Ling V, Chan HS.
    Arch Ophthalmol; 1996 Nov; 114(11):1321-8. PubMed ID: 8906022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K, Pal N, Kosek S, Holm S, All-Ericsson C.
    Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
    [Abstract] [Full Text] [Related]

  • 20. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM, Kingston J, Hungerford JL.
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.